Synthetic Procollagen III N-Terminal Propeptide (PIIINP)
P3NP; N-Propeptide Of Type III Procollagen; Procollagen III Amino Terminal Propeptide
- Product No.SPA573Hu01
- Organism SpeciesHomo sapiens (Human) Same name, Different species.
- SourcePeptide synthesis
- Predicted Molecular Mass1791.1Da
- Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
- Traits Freeze-dried powder
- Purity> 97%
- Isoelectric Pointn/a
Immunogen; Blocking Peptide.
If bio-activity of the protein is needed, please check active protein.
200µg 1mg 5mg
For more details, please contact local distributors! US$ 300 FREE TRIAL
For more details, please contact local distributors! US$ 600 FREE TRIAL
For more details, please contact local distributors! US$ 1800 FREE TRIAL
For more details, please contact local distributors! US$ 4500 FREE TRIAL
For more details, please contact local distributors!
Reconstitute in PBS or others.
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
|Molecular Biology Reports||Characterization of the specific and sustained GH1 expression induced by rAAV2/1 in normal adult male rats PubMed: 20204528|
|Obesity Surgery||A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis PubMed: 20532833|
|Liver Biopsy||Comparison of Five Liver Fibrosis Indexes with Serum Levels of Laminin and N Terminal Peptide of Procollagen Type III in Chronic Hepatitis Patients Intechopen: 18785|
|Trials||Is there benefit in optimising heart failure treatment in over-80 year-old patients? (HF-80 study): study protocol for a randomized controlled trial. Trials: 1745-6215|
|American Journal of Hypertension||Aliskiren and Perindopril Reduce the Levels of Transforming Growth Factor-β in Patients With Non-Diabetic Kidney Disease Nature: 201214|
|Arthritis Research and Therapy||Raised circulating tenascin-C in rheumatoid arthritis. PubMed: 23193984|
|American Heart Journal||Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure. PubMed: 23067911|
|hepatology research||Diagnostic potential of serum direct markers and non-invasive fibrosis models in patients with chronic hepatitis B. PubMed: 22734888|
|Digestive and Liver Disease||Effects of coffee consumption in chronic hepatitis C: a randomized controlled trial Pubmed: 23238034|
|Journal of Infectious Diseases||Procollagen III N-terminal propeptide and desmosine are released by matrix destruction in pulmonary tuberculosis Pubmed: 23922364|
|International Urogynecology Journal||Prevalence, etiology and risk factors of pelvic organ prolapse in premenopausal primiparous women Springer: Source|
|Journal of Clinical and Experimental Hepatology||Protective Effects of Norursodeoxycholic Acid Versus Ursodeoxycholic Acid on Thioacetamide-induced Rat Liver Fibrosis ScienceDirect: S0973688314000073|
|Der Urologe||Retroperitoneale Fibrose Springer:Source|
|Ultrasound in Obstetrics & Gynecology||The status of the pelvic floor in young primiparous women Wiley:Source|
|PLoS One.||Clinical significance of markers of collagen metabolism in rheumatic mitral valve disease Pubmed:24603967|
|Clin Chim Acta.||Serum and urinary procollagen III aminoterminal propeptide as a biomarker of obstructive nephropathy in children Pubmed:24768785|
|BMC Gastroenterol.||Fast food diet with CCl4 micro-dose induced hepatic-fibrosis-a novel animal model Pubmed:24884574|
|Toxicology.||DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2 Pubmed:24945829|
|Southeast Asian J Trop Med Public Health.||Correlation of HBsAg titers with serum fibrotic maker in patients with chronic hepatitis B infection. Pubmed:24974647|
|The American Journal of Cardiology||Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in Fabry disease Pubmed:25073565|
|Ann Rheum Dis.||B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease Pubmed:25143523|
|Scientific Reports||Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients with Hypertension PubMed: 25747153|
|Int J Mol Sci||The Multi-Biomarker Approach for Heart Failure in Patients with Hypertension PubMed: 25984599|
|Viral Hepatitis Journal||The Relationship of the Degree of Hepatic Fibrosis with Hyaluronic Acid, Type 4 Collagen, and Procollagen Type 3 N-Terminal Peptide Levels in Patients with Chronic Viral Hepatitis Openview: 8A0B8C97D72C61741371F33508760B75|
|International Journal of Experimental Pathology||Pathological characterization and morphometric analysis of hepatic lesions in SHRSP5/Dmcr, an experimental non-alcoholic steatohepatitis model, induced by high-fat and high-cholesterol diet doi:10.1111|
|Heart Rhythm.||Prognostic value of collagen turnover biomarkers in cardiac resynchronization therapy: A subanalysis of the TRUST CRT randomized trial population Pubmed:26776557|
|BMJ Open Sport Exerc Med||Procollagen markers in microdialysate can predict patient outcome after Achilles tendon rupture content:2|
|Inflammation Research||Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy pubmed:27516211|
|Heart & Vessels||Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR pubmed:28004175|
|american journal of physiology-renal physiology||Extracellular microRNA signature in chronic kidney disease. pubmed:28077372|
|Cellular Physiology and Biochemistry||Renal Denervation Attenuates Multi-Organ Fibrosis and Improves Vascular Remodeling in Rats with Transverse Aortic Constriction Induced Cardiomyopathy pubmed:27889753|
|PLoS One.||Procollagen C-Proteinase Enhancer 1 (PCPE-1) as a Plasma Marker of Muscleand Liver Fibrosis in Mice. pubmed:27458976|
|International Journal of Cardiology||5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - apreliminary approach to clinical utility. pubmed:27526355|
|Transplant Proc||Urinary Type III Procollagen Is Associated With Chronic Allograft Dysfunction and Predicts Graft Survival. pubmed:28219585|
|Knee Surg Sports Traumatol Arthrosc||Achilles tendon rupture healing is enhanced by intermittent pneumatic compression upregulating collagen type I synthesis pubmed:28668970|
|Antiviral Therapy||Association of HIV infection with biomarkers of kidney injury and fibrosis in the Multicenter AIDS Cohort Study pubmed:28054933|
|Molecular Medicine Reports||Profilin‑1 contributes to cardiac injury induced by advanced glycation end‑products in rats pubmed:28901418|
|Biomarkers Medicial||Relationship of biomarkers of extracellular matrix with myocardial function in Type 2 diabetes mellitus pubmed:28685602|
|Heart and Vessels||Left ventricular reverse remodeling is not related to biopsy‑detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR 10.1007/s00380-016-0930-y|
|Clinical Infectious Diseases||Matrix Degradation in Human Immunodeficiency Virus Type 1–Associated Tuberculosis and Tuberculosis Immune Reconstitution Inflammatory Syndrome: A Prospective Observational Study 10.1093/cid/cix231|
|Cytokine||12-month patterns of serum markers of collagen synthesis, transforming growth factor and connective tissue growth factor are similar in new-onset and chronic dilated cardiomyopathy in patients both with and without cardiac fibrosis. pubmed:28460256|
|Advanced Healthcare Materials||Prognostic value of fibrosis-related markers in dilated cardiomyopathy: A link between osteopontin and cardiovascular events. pubmed:29120858|